GENinCode (LSE:GENI) Price-to-Tangible-Book : 6.88 (As of Jun. 24, 2024)

View and export this data going back to 2021. Start your Free Trial

What is GENinCode Price-to-Tangible-Book?

As of today (2024-06-24), GENinCode's share price is £0.06875. GENinCode's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was £0.01. Hence, GENinCode's Price to Tangible Book Ratio of today is 6.88.

The historical rank and industry rank for GENinCode's Price-to-Tangible-Book or its related term are showing as below:

LSE:GENI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.98 Med: 2.3 Max: 6.88
Current: 6.88

During the past 5 years, GENinCode's highest Price to Tangible Book Ratio was 6.88. The lowest was 0.98. And the median was 2.30.

LSE:GENI's Price-to-Tangible-Book is ranked worse than
80% of 165 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.47 vs LSE:GENI: 6.88

A closely related ratio is called PB Ratio. As of today, GENinCode's share price is £0.06875. GENinCode's Book Value per Sharefor the quarter that ended in Dec. 2023 was £0.01. Hence, GENinCode's P/B Ratio of today is 5.29.

GENinCode Price-to-Tangible-Book Historical Data

The historical data trend for GENinCode's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GENinCode Price-to-Tangible-Book Chart

GENinCode Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

2.30

0.98

5.25

GENinCode Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			2.30	1.65	0.98	2.55	5.25

Competitive Comparison of GENinCode's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, GENinCode's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GENinCode's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GENinCode's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where GENinCode's Price-to-Tangible-Book falls into.

GENinCode Price-to-Tangible-Book Calculation

GENinCode's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.06875	/	0.01
	=	6.88

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

GENinCode Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of GENinCode's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

GENinCode (LSE:GENI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GENinCode PLC (LSE:GENI) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP

Website

https://www.genincode.com

GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment being sale of kits and provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain and United Kingdom.